Stericycle (SRCL) Reports In-Line Q2 EPS, Revenue Light
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Imperial Capital Downgrades Stericycle (SRCL) to Underperform
July 29, 2016 10:26 AM EDTImperial Capital downgraded Stericycle (NASDAQ: SRCL) from In-Line to Underperform with a price target of $93.50 (from $100.00).
Analyst Scott Levine commented, "We are lowering our rating on SRCL shares to Underperform from In-Line, and are lowering our one-year price target to $93.50 from $100. Our... More
